Mitchell Glass Md Email & Phone Number
Who is Mitchell Glass Md? Overview
A concise factual answer block for searchers comparing this professional profile.
Mitchell Glass Md is listed as Head of teams that developed 6 approved drugs and devices at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates, based in Wilmington, Delaware, United States. AeroLeads shows a matched LinkedIn profile for Mitchell Glass Md.
Mitchell Glass Md previously worked as CMO TNF Pharma at Tnf Pharma (Nasd Tnfa) and President and CMO at Mymd Pharmaceuticals. Mitchell Glass Md studied at The University Of Chicago Pritzker School Of Medicine.
Email format at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates
This section adds company-level context without repeating Mitchell Glass Md's masked contact details.
Review company-level records connected to Mitchell Glass Md before choosing the right outreach path.
About Mitchell Glass Md
I am looking forward to an exciting 2024CAT is moving forward WITH ORAL AND INHALED nadolol for chronic bronchitis and smoking cessationCAT is devising a plan for inhaled zafirlukast in pediatric asthma and early OTC switch Accolade has filed its IND in the US for nasal formulation of zafirlukast in allergen challengeBroom Street Associates has added 5 new consultants, and is actively consulting from oral health to GBMI am pleased and honored to announce that I have been appointed CEO, CMO and Director of MyMD , (NASD MYMD). Anne and I remain healthy not quite wealthy and very happy
Mitchell Glass Md's current company
Company context helps verify the profile and gives searchers a useful next step.
Mitchell Glass Md work experience
A career timeline built from the work history available for this profile.
Cmo Tnf Pharma
Chief Executive Officer
Principal
Consulting to early-stage pharmaceuticals and device companies for FDA and EMA (and CDE).Product strategy including non-clinical and clinical development.Development of new intellectual property.
Chairman And Ceo
Developing topical (non-oral) formulations of Zafirlukast for allergic inflammation.
Executive Vice President, R&D And Director
Led all aspects of research and developments. Member of Board of Directors.CEO of Invion, Inc.
Ceo And Director
Managed the development of ophthalmic drugs through Phase III.Established technology assessment of Japanese drug targets.Represented the United States on main Board of Directors.
Mitchell Glass Md education
Education record
Ab 73 Md77, Biology, Medicine
Frequently asked questions about Mitchell Glass Md
Quick answers generated from the profile data available on this page.
What company does Mitchell Glass Md work for?
Mitchell Glass Md works for CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates.
What is Mitchell Glass Md's role at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates?
Mitchell Glass Md is listed as Head of teams that developed 6 approved drugs and devices at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates.
Where is Mitchell Glass Md based?
Mitchell Glass Md is based in Wilmington, Delaware, United States while working with CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates.
What companies has Mitchell Glass Md worked for?
Mitchell Glass Md has worked for Chronic Airway Therapeutics, Broom Street Associates, Tnf Pharma (Nasd Tnfa), Mymd Pharmaceuticals, Chronic Airway Therapeutics, and Broom Street Associates Llc.
How can I contact Mitchell Glass Md?
You can use AeroLeads to view verified contact signals for Mitchell Glass Md at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates, including work email, phone, and LinkedIn data when available.
What schools did Mitchell Glass Md attend?
Mitchell Glass Md studied at The University Of Chicago Pritzker School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial